Tech Company Financing Transactions

3T Biosciences Funding Round

Westlake Village BioPartners and Lightspeed Venture Partners participated in a $40 million Series A funding round for 3T Biosciences. The financing round was announced on 8/25/2022.

Transaction Overview

Company Name
Announced On
8/25/2022
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds from the financing will be used to help accelerate 3T from a research-focused company to a clinical-stage company by bringing novel targets into clinical development.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA 94105
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
3T Biosciences is in the T-cell therapy space, meaning that it is among a growing group of new start-ups working to bolster the body's own immune system to fight cancer.
Profile
3T Biosciences LinkedIn Company Profile
Social Media
3T Biosciences Company Twitter Account
Company News
3T Biosciences News
Facebook
3T Biosciences on Facebook
YouTube
3T Biosciences on YouTube

Management Team

Title
Name
Email & Social
Founder
Luke Lee
  Luke Lee LinkedIn Profile  Luke Lee Twitter Account  Luke Lee News  Luke Lee on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/25/2022: AtomVie Global Radiopharma venture capital transaction
Next: 8/25/2022: Psych Hub venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary